[HTML][HTML] Metabolomic characterization reveals ILF2 and ILF3 affected metabolic adaptions in esophageal squamous cell carcinoma

B Zang, W Wang, Y Wang, P Li, T Xia, X Liu… - Frontiers in Molecular …, 2021 - frontiersin.org
Esophageal cancer (EC) is a common malignant disease in eastern countries. However, a
study of the metabolomic characteristics associated with other biological factors in …

Proteomic and metabolic signatures of esophageal squamous cell carcinoma

K Karagoz, HL Lehman, DB Stairs… - Current cancer drug …, 2016 - ingentaconnect.com
Esophageal squamous cell carcinoma (ESCC), which is the most common subtype of
esophageal cancers, is the sixth leading cause of cancer deaths worldwide with a five-year …

[HTML][HTML] Untargeted metabolomics analysis of esophageal squamous cell carcinoma discovers dysregulated metabolic pathways and potential diagnostic biomarkers

ZJ Zhu, Z Qi, J Zhang, WH Xue, LF Li, ZB Shen… - Journal of …, 2020 - ncbi.nlm.nih.gov
Background: Esophageal squamous cell carcinoma (ESCC) is one of the most fatal
diseases worldwide. Because early diagnosis is difficult, ESCC is mostly diagnosed at an …

[HTML][HTML] Combined metabolomic analysis of plasma and tissue reveals a prognostic risk score system and metabolic dysregulation in esophageal squamous cell …

Z Chen, Y Dai, X Huang, K Chen, Y Gao, N Li… - Frontiers in …, 2020 - frontiersin.org
Background: Esophageal squamous cell carcinoma (ESCC) is a gastrointestinal malignancy
with a poor prognosis. Although studies have shown metabolic reprogramming to be linked …

[HTML][HTML] Integrating transcriptome and metabolome variability to reveal pathogenesis of esophageal squamous cell carcinoma

J Cheng, Q Liu, H Jin, D Zeng, Y Liao, Y Zhao… - … et Biophysica Acta (BBA …, 2021 - Elsevier
Abstract Background Esophageal Squamous Cell Carcinoma (ESCC) is an aggressive
malignancy, leading to more than 250,000 deaths in China every year. However, the …

Tissue-based metabolomics reveals metabolic biomarkers and potential therapeutic targets for esophageal squamous cell carcinoma

Z Chen, Y Gao, X Huang, Y Yao, K Chen… - … of Pharmaceutical and …, 2021 - Elsevier
Prognosis for esophageal squamous cell carcinoma (ESCC) is poor, so it is essential to
develop a more complete understanding of the disease. The purpose of this study was to …

[HTML][HTML] Global and targeted metabolomics of esophageal squamous cell carcinoma discovers potential diagnostic and therapeutic biomarkers

J Xu, Y Chen, R Zhang, Y Song, J Cao, N Bi… - Molecular & Cellular …, 2013 - ASBMB
Diagnostic and therapeutic biomarkers useful for esophageal squamous cell carcinoma
(ESCC) have the ability to increase the long term survival of cancer patients. A …

LC–MS-based serum metabolomic analysis reveals dysregulation of phosphatidylcholines in esophageal squamous cell carcinoma

SA Mir, P Rajagopalan, AP Jain, AA Khan, KK Datta… - Journal of …, 2015 - Elsevier
Esophageal squamous cell carcinoma (ESCC) is one of the most aggressive cancers with
poor prognosis. Here, we carried out liquid chromatography–quadrupole time-of-flight mass …

[HTML][HTML] Global metabolomics reveals potential urinary biomarkers of esophageal squamous cell carcinoma for diagnosis and staging

J Xu, Y Chen, R Zhang, J He, Y Song, J Wang… - Scientific Reports, 2016 - nature.com
We performed a metabolomics study using liquid chromatography-mass spectrometry (LC-
MS) combined with multivariate data analysis (MVDA) to discriminate global urine profiles in …

Metabolomic profiling reveals potential biomarkers in esophageal cancer progression using liquid chromatography-mass spectrometry platform

H Zhang, L Wang, Z Hou, H Ma, B Mamtimin… - Biochemical and …, 2017 - Elsevier
Esophageal cancer (EC) is one of the most common malignancies with poor prognosis.
Metabolomics has been shown to be a powerful approach to discover the potential …